Longitude Prize on Dementia
Overview
Longitude Prize on Dementia is a challenge prize that incentivizes the development of AI and technology-based tools to help people living with dementia maintain their independence for longer.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| PhAST Diagnostics | - | Grant | Co-investor |
| Clairvoyant Networks, Inc. | Oct 2024 | Grant | Co-investor |
| SuperSenses | Oct 2024 | Grant | Co-investor |
| eargym | - | Grant | Co-investor |
| Circadacare | Jan 2024 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Longitude Prize on Dementia based?
Longitude Prize on Dementia is headquartered in London, United Kingdom.
When was Longitude Prize on Dementia founded?
Longitude Prize on Dementia was founded in 2022.
How many portfolio companies does Longitude Prize on Dementia have?
Longitude Prize on Dementia has 7 portfolio companies in Caplight's dataset.
What are some companies in Longitude Prize on Dementia's portfolio?
Portfolio companies visible on Caplight include PhAST Diagnostics, Clairvoyant Networks, Inc., SuperSenses, eargym, Circadacare.
What was Longitude Prize on Dementia's most recent investment shown here?
Longitude Prize on Dementia's most recent investment in this portfolio sample was in SuperSenses in 2024.
What sectors does Longitude Prize on Dementia focus on?
Longitude Prize on Dementia focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Media, Entertainment & Gaming, Enterprise Software, Real Estate & PropTech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does Longitude Prize on Dementia focus on?
Stage focus information for Longitude Prize on Dementia is not publicly available.